Lily Colahan

Associate

+1 617 937 2432
lcolahan@cooley.com

Lily Colahan's corporate practice includes advising public and private companies in a broad array of business activities and transactions, with a focus on the technology and life sciences sectors.

Download full bio

Experience

  • Karuna Therapeutics $103 million IPO 

  • Akero Therapeutics - $106 Million IPO 

  • Avedro – $70 Million IPO 

Education

  • Fordham University School of Law
    JD, magna cum laude, 2014

  • Tufts University
    BA, 2011


Admissions & Credentials

Massachusetts

New York

Media & Insight

Contact

+1 617 937 2432 office
lcolahan@cooley.com

500 Boylston Street
14th Floor
Boston, MA 02116-3736